Article
Breast cancer screening adherence after multigene panel testing among women with pathogenic variants in moderate-risk genes or with empirically increased breast cancer risk.
Breast cancer research and treatment - 10 Jul 2026
Comeaux Jacob G, Gutierrez Natalia, Ricker Charité N, Nie Qi, Nguyen Averi, Garcia Ivan, Chang Emmeline Y, Waggoner Rebecca M, Groshen Susan, Lerman Caryn, Spicer Darcy, Culver Julie O
Abstract excerpt
PURPOSE: To identify factors associated with adherence to breast cancer (BC) screening among women with a pathogenic or likely pathogenic (P/LP) variant in a moderate-risk gene, ATM, BARD1, CHEK2, RAD51C, and RAD51D or with empiric lifetime risk ≥ 20%. METHODS: We reviewed medical records of women without breast cancer who underwent genetic counseling and testing and were advised to undergo annual breast MRI and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.